Pancreatic Cancer Research

ResearcherUniversity Hospital in HalleActive in the last 2 years

Artur Rebelo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5267-079X; OpenAlex author ID A5028033796. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: none · 2025: 4 papers · 2026: 4 papers

Papers 13

  1. R0 Resection improves survival after multivisceral resection for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.isci.2026.117352↗
  2. International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot. Co-author DOI 10.1016/j.suronc.2026.102580↗
  3. Hybrid hepatic artery debranching for pancreatic cancer with celiac axis occlusion. Co-author DOI 10.21037/hbsn-2025-714↗
  4. Surgery in Oligometastatic Pancreatic Cancer: Narrative Systematic Review. Last author DOI 10.3390/cancers18111699↗
  5. Future of Pancreatic Cancer Therapy: Getting Better, But not Good Enough Ye. Co-author DOI 10.1016/j.arcmed.2025.103336↗
  6. Toward a new standard: Sequential multi-agent neoadjuvant chemotherapy in resectable pancreatic cancer. Co-author DOI 10.1016/j.ccell.2025.10.003↗
  7. Integrating surgery into multimodal treatment for locally advanced pancreatic cancer: beyond the boundaries of systemic therapy. Co-author DOI 10.21037/hbsn-2025-342↗
  8. Investigating survival patterns in pancreatic adenocarcinoma over two decades after introducing FOLFIRINOX. Last author DOI 10.21037/jgo-2025-630↗
  9. Intestinal autotransplantation: the next level of complexity in locally advanced pancreatic cancer. Co-author DOI 10.21037/hbsn-23-306↗
  10. Cholesterol Metabolism in Pancreatic Cancer. Co-author DOI 10.3390/cancers15215177↗
  11. Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis. First author DOI 10.1186/s12944-021-01476-y↗
  12. Do arterial resections improve survival in pancreatic cancer?-a narrative review. Co-author DOI 10.21037/cco-21-39↗
  13. Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells. First author DOI 10.3390/cancers10010003↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jorg H. Kleeff · 11 shared papers, 2017–2026 · strength 3.61
  2. Ulrich Ronellenfitsch · 4 shared papers, 2021–2026 · strength 1.22
  3. Yoshiaki Sunami · 4 shared papers, 2017–2025 · strength 0.92
  4. Jessica Döbereiner · 3 shared papers, 2021–2025 · strength 0.90
  5. Johannes Klose · 2 shared papers, 2025–2026 · strength 0.66
  6. Thomas Theodor Werner Seufferlein · 1 shared paper, 2025 · strength 0.42
  7. Christoph Michalski · 1 shared paper, 2026 · strength 0.39
  8. Rosa Klotz · 1 shared paper, 2026 · strength 0.39
  9. Rubing Bai · 1 shared paper, 2021 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.